Tight Glycemic Control and Cardiovascular Effects in Type 2 Diabetic Patients

Diabetes Mellitus (DM) with poor glycemic control is one of the leading causes for cardiovascular mortality in diabetic patients. Tight glycemic control with glycosylated haemoglobin of <7 gms% is recommended as a routine and < 6.5 gms% is recommended for young and newly diagnosed diabetics. Treatment goal aims at achieving near normal blood glucose level, and directed at management of other co morbid conditions such as obesity, hypertension and dyslipidemia. Oral hypoglycemic agents are the preferred drugs, alone or in combination. Preference for glitazones is declining due to the increasing evidences of associated adverse events. Gliptins appear as promising agents with lesser tendency to cause hypoglycemia, but their long term safety and efficacy is yet to be established. We emphasize the role of preventive measures in prediabetics and in established DM, treatment should be individualized and customized to minimize hypoglycemic effects and to retain quality of life.

• Publication year

  2014

• Venue

  Heart Views

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/1995-705X.151084PMID 25774253PMCID 4348983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

  2016cited by this paper
• Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies

  2013cited by this paper
• Tight glycemic control may increase regenerative potential of myocardium during acute infarction.

  2012cited by this paper
• Elderly patients may benefit from tight glucose control.

  2012cited by this paper
• Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus

  2012cited by this paper
• Release

  2012cited by this paper
• Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan

  2012cited by this paper
• Gliptin versus a sulphonylurea as add-on to metformin.

  2012cited by this paper
• Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic, Blood Pressure and Lipid Control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33)

  2012cited by this paper
• Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature.

  2012cited by this paper
• Standards of Medical Care in Diabetes—2013

  2012cited by this paper
• Association Between Glycemic Control and Hip Fracture

  2012cited by this paper
• Managing diabetes during the Muslim fasting month of Ramadan.

  2012cited by this paper
• Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control

  2011cited by this paper
• Does tight glucose control prevent myocardial injury and inflammation?

  2011cited by this paper
• Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

  2011cited by this paper
• Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting.

  2011cited by this paper
• Diabetes and Ramadan: An Update On Use of Glycemic Therapies During Fasting

  2011cited by this paper
• Glycemic control in the ICU.

  2011cited by this paper
• A cohort study of acute pancreatitis in relation to exenatide use

  2011cited by this paper
• Attitudinal determinants of fasting in type 2 diabetes mellitus patients during Ramadan.

  2011cited by this paper
• Care of elderly patients with diabetes mellitus: a focus on frailty.

  2010cited by this paper
• Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.

  2010cited by this paper
• Blood Glucose Control and Coronary Heart Disease

  2010cited by this paper
• Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?

  2010cited by this paper
• The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.

  2010cited by this paper
• Update in diabetes and cardiovascular disease: synthesizing the evidence from recent trials of glycemic control to prevent cardiovascular disease

  2010cited by this paper
• Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis.

  2010cited by this paper
• Effects of moderate intensity glycemic control after cardiac surgery.

  2010cited by this paper
• UvA-DARE ( Digital Academic Repository ) Patients with diabetes in the intensive care unit ; not served by treatment , yet protected ?

  2010cited by this paper
• Advances in pharmacotherapy of Type 2 diabetes (Part-3: The gliptins)

  2010cited by this paper
• Lessons Learned from Glycemia Control Studies

  2010cited by this paper
• Glucose lowering and cardiovascular disease: what do we know and what should we do?

  2010cited by this paper
• Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast

  2010cited by this paper
• Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management

  2010cited by this paper
• Near-normal glycemia for critically ill patients receiving nutrition support: fact or folly

  2010cited by this paper
• Glycemic Control in the ICU

  2010cited by this paper
• Diabetes and fasting during Ramadan

  2010cited by this paper
• Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically

  2010cited by this paper
• [Glycemic index and glycemic load in the prevention and treatment of type 2 diabetes mellitus].

  2009cited by this paper
• Tight glycemic control using an artificial pancreas to control perioperative hyperglycemia decreases surgical site infection in pancreatectomized or hepatectomized patients.

  2009cited by this paper
• Is tight glycemic control in type 2 diabetes really worthwhile? No.

  2009cited by this paper
• Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients.

  2009cited by this paper
• Glycemic Control in the Medical Intensive Care Unit

  2009cited by this paper
• Motor Vehicle Crashes in Diabetic Patients with Tight Glycemic Control: A Population-based Case Control Analysis

  2009cited by this paper
• Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients

  2009cited by this paper
• A Summary of the ADVANCE Trial

  2009cited by this paper
• Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

  2009cited by this paper
• Relationship between perioperative glycemic control and postoperative infections.

  2009cited by this paper
• Tight perioperative glycemic control using an artificial endocrine pancreas

  2009cited by this paper
• Tight glycemic control may favor fibrinolysis in patients with sepsis*

  2009cited by this paper
• Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

  2009cited by this paper
• Impact of Glycemic Treatment Choices on Cardiovascular Complications in Type 2 Diabetes

  2009cited by this paper
• Therapeutic Implications of Diabetes in Cardiovascular Disease

  2009cited by this paper
• Is tight glycemic control in type 2 diabetes really worthwhile? Yes.

  2009cited by this paper
• The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients.

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients

  2009cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

  2008cited by this paper
• Importance of glycemic control on the course of glomerular filtration rate in type 2 diabetes with hypertension and microalbuminuria under tight blood pressure control.

  2008cited by this paper
• Tight Glycemic Control in Critically Injured Trauma Patients

  2007cited by this paper
• Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.

  2007cited by this paper
• The benefits of tight glycemic control in type 2 diabetes mellitus.

  2007cited by this paper
• Renal protection in diabetes: role of glycemic control.

  2006cited by this paper
• Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital.

  2006cited by this paper
• Cost considerations with tight glycemic control in the acute care setting.

  2006cited by this paper
• Glycemia and cognitive function in older adults using glucose-lowering drugs.

  2006cited by this paper
• Diabetes management at the end of life: transitioning from tight glycemic control to comfort.

  2006cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Glycemic control and the risk of multiple microvascular diabetic complications.

  2005cited by this paper
• Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events

  2004cited by this paper
• New insights into diastolic heart failure: role of diabetes mellitus.

  2004cited by this paper
• [Diabetes mellitus, left ventricular dysfunction and congestive heart failure].

  2004cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• Non‐linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy

  2000cited by this paper
• The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial

  1995cited by this paper

• Poor glycaemic control in type 2 diabetes compromises leukocyte oxygen consumption rate, OXPHOS complex content and neutrophil-endothelial interactions

  2025cites this paper
• Evaluating Risk Factors and the Burden of Silent Myocardial Ischemia Among Diabetic Patients

  2024cites this paper
• Intranasal transmucosal drug delivery: An alternative approach to the parenteral route for medical emergencies

  2023cites this paper
• Vascular hyperacetylation is associated with vascular smooth muscle dysfunction in a rat model of non-obese type 2 diabetes

  2022cites this paper
• Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation

  2021cites this paper
• Effect of Pharmacist-Led Intervention on Progression of Diabetic Complications at Two Tertiary Care Hospitals of Malaysia

  2021cites this paper
• Hemoglobin A1c in Patients with Diabetes Predict Long-Term Mortality Following Coronary Artery Surgery

  2021cites this paper
• Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.

  2021cites this paper
• Correlation of CA 19-9 with HbA1c in prediabetic and diabetic groups

  2021cites this paper
• Human Tongue Thermography Could Be a Prognostic Tool for Prescreening the Type II Diabetes Mellitus

  2020cites this paper
• Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glycemic Control

  2020cites this paper
• Factors associated with glycemic control among South African adult residents of Mkhondo municipality living with diabetes mellitus

  2020cites this paper
• Cardio-protective effects of a dioxidovanadium(V) complex in male sprague–dawley rats with streptozotocin-induced diabetes

  2020cites this paper
• Management and glycemic control of patients with type 2 diabetes mellitus at primary care level in Kedah, Malaysia: A statewide evaluation

  2019cites this paper
• Anti-diabetic activity of aerial parts of Sarcopoterium spinosum

  2017cites this paper
• Post Prandial Hyperglycemia: A Real Threat for Patients with Type 2 Diabetes Mellitus

  2017cites this paper
• Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study

  2016cites this paper
• Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus).

  2016cites this paper